scorecardresearch
Add as a preferred source on Google
Sunday, September 28, 2025
TopicPharma industry

Topic: pharma industry

Indian drugmakers relieved but wary as US exempts pharma sector from new trade tariffs

Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.

8 dead in Hyderabad pharma factory explosion, search & rescue ops ongoing

Telangana CM Reddy expressed his grief directing that all steps be taken to save the workers & provide them advanced medical care.

Don’t let foreign big pharma block biosimilars. Govt should boost access in India

Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.

Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

Leading drugmakers express apprehension over CDSCO’s proposal to permit generic alternatives for key medications, emphasizing the risk of compromised drug quality.

SubscriberWrites: Pharma industry – Yearning for reforms

Despite the critical importance of the Pharma Industry, no attempts were made to resolve the issues & transform the industry.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Tirzepatide, another diabetes drug cleared for weight loss in US, yet to get regulator nod in India

In clinical trials, tirzepatide by Eli Lilly has shown to reduce body weight by up to 22.5 percent, on average, after about 72 weeks, according to the company.

No dent in Indian pharma exports despite quality concerns over cough syrups, data shows

WHO may be probing allegations of 20 substandard paracetamol & cough syrups by 15 manufacturers from India, but these allegations seem to have little impact on export of medicines.

Modi govt likely to bring in stricter pan-Indian system to recall substandard drugs from market

Provision included in draft bill to be approved by Union cabinet. Existing drugs law mentions product recall, but doesn't specify timelines or system for auditing and accountability.

Mandatory test for Indian pharma products in Gambia after cough syrup deaths

The new rule focusses on accessing Gambia's reliance on India's $42 billion pharmaceutical industry since the contamination came to light last year.

On Camera

We can’t just blame Muslims and Englishmen for shattered Hindu unity: RSS chief Deoras

In May 1974, RSS chief Madhukar Dattatraya Deoras spoke at a lecture series in Pune about caste-based discrimination and social equality within the Hindu fold.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.